Martin Rehn1, Peter-Martin Krarup2, Lise H Christensen3, Jakob B Seidelin2, Magnus S Ågren2,4,5, Ingvar Syk1. 1. 1 Department of Surgery, Skåne University Hospital , Malmö, Sweden . 2. 2 Digestive Disease Center, Bispebjerg Hospital, University of Copenhagen , Copenhagen, Denmark . 3. 3 Department of Pathology, Bispebjerg Hospital, University of Copenhagen , Copenhagen, Denmark . 4. 4 Copenhagen Wound Healing Center, Bispebjerg Hospital, University of Copenhagen , Copenhagen, Denmark . 5. 5 Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen , Copenhagen, Denmark .
Abstract
BACKGROUND: Emergency operations performed on an obstructed colon are accompanied by an increased risk of anastomotic insufficiency. Tissue-destructive matrix metalloproteinase (MMP) activity is elevated in the obstructed colon and contributes to a loss of suture-holding submucosal collagen, which may be mediated by tumor necrosis factor (TNF)-α. Our aim was to study the effect of the non-selective MMP and TNF-α converting enzyme (TACE) inhibitor GM6001 (30 mg/kg) on anastomosis repair in obstructed left colon. GM6001 has been proved to be highly efficacious in elective anastomosis rodent models. METHODS: A partial obstruction of the distal colon was induced in male Sprague-Dawley rats. After 4 d the obstructed colonic segment was resected, and an end-to-end anastomosis was constructed. Seven days later, the anastomoses were evaluated for clinical leakage. Histopathological and immunohistochemical assessments were also performed. Finally, the direct effect of GM6001 on epithelialization was studied in cultured colonic epithelial cells. RESULTS: Unlike the robust beneficial effect on anastomosis under uncomplicated conditions, here GM6001 had a negative impact on anastomotic wound healing following colonic obstruction and substantially (p=0.004) more rats in the GM6001 group (75%) than in the control group (11%) had developed anastomotic leakage. In the anastomotic wounds, the myofibroblast abundance and cell proliferation were similar in the two groups. Histologically, GM6001 treatment resulted in wider and minimally epithelialized wounds that were commonly necrotic on the luminal side and infiltrated with numerous granulocytes. In vitro, GM6001 also delayed (p=0.026) epithelialization of denuded intestinal epithelium grown on type I collagen. CONCLUSIONS: Non-selective MMP/TACE inhibition with GM6001 increased the anastomotic complications following colon obstruction. Inhibition of epithelialization is one possible mechanism responsible for the increased leakage following GM6001 treatment.
BACKGROUND: Emergency operations performed on an obstructed colon are accompanied by an increased risk of anastomotic insufficiency. Tissue-destructive matrix metalloproteinase (MMP) activity is elevated in the obstructed colon and contributes to a loss of suture-holding submucosal collagen, which may be mediated by tumor necrosis factor (TNF)-α. Our aim was to study the effect of the non-selective MMP and TNF-α converting enzyme (TACE) inhibitor GM6001 (30 mg/kg) on anastomosis repair in obstructed left colon. GM6001 has been proved to be highly efficacious in elective anastomosis rodent models. METHODS: A partial obstruction of the distal colon was induced in male Sprague-Dawley rats. After 4 d the obstructed colonic segment was resected, and an end-to-end anastomosis was constructed. Seven days later, the anastomoses were evaluated for clinical leakage. Histopathological and immunohistochemical assessments were also performed. Finally, the direct effect of GM6001 on epithelialization was studied in cultured colonic epithelial cells. RESULTS: Unlike the robust beneficial effect on anastomosis under uncomplicated conditions, here GM6001 had a negative impact on anastomotic wound healing following colonic obstruction and substantially (p=0.004) more rats in the GM6001 group (75%) than in the control group (11%) had developed anastomotic leakage. In the anastomotic wounds, the myofibroblast abundance and cell proliferation were similar in the two groups. Histologically, GM6001 treatment resulted in wider and minimally epithelialized wounds that were commonly necrotic on the luminal side and infiltrated with numerous granulocytes. In vitro, GM6001 also delayed (p=0.026) epithelialization of denuded intestinal epithelium grown on type I collagen. CONCLUSIONS: Non-selective MMP/TACE inhibition with GM6001 increased the anastomotic complications following colon obstruction. Inhibition of epithelialization is one possible mechanism responsible for the increased leakage following GM6001 treatment.
Authors: Magnus S Agren; Thomas L Andersen; Ursula Mirastschijski; Ingvar Syk; Christine Bruun Schiødt; Vikas Surve; Jan Lindebjerg; Jean-Marie Delaissé Journal: Surgery Date: 2006-07 Impact factor: 3.982
Authors: Nuh N Rahbari; Jürgen Weitz; Werner Hohenberger; Richard J Heald; Brendan Moran; Alexis Ulrich; Torbjörn Holm; W Douglas Wong; Emmanuel Tiret; Yoshihiro Moriya; Søren Laurberg; Marcel den Dulk; Cornelis van de Velde; Markus W Büchler Journal: Surgery Date: 2009-12-11 Impact factor: 3.982
Authors: Magnus S Ågren; Thomas L Andersen; Line Andersen; Christine Bruun Schiødt; Vikas Surve; Troels T Andreassen; Juha Risteli; Lennart E Franzén; Jean-Marie Delaissé; Anne-Marie Heegaard; Lars N Jorgensen Journal: Int J Colorectal Dis Date: 2010-12-31 Impact factor: 2.571
Authors: A McGarry Houghton; William O Hartzell; Clinton S Robbins; F Xavier Gomis-Rüth; Steven D Shapiro Journal: Nature Date: 2009-06-17 Impact factor: 49.962
Authors: Björn Pasternak; Martin Rehn; Line Andersen; Magnus S Agren; Anne-Marie Heegaard; Pentti Tengvall; Per Aspenberg Journal: Int J Colorectal Dis Date: 2007-11-28 Impact factor: 2.571
Authors: Peter-Martin Krarup; Mikkel Eld; Lars Nannestad Jorgensen; Mark Berner Hansen; Magnus S Ågren Journal: Int J Colorectal Dis Date: 2017-07-17 Impact factor: 2.571
Authors: Marie Kjaer; Wayne Russell; Peter Schjerling; Elena Cottarelli; Kennet N Christjansen; Ditte M G Olsen; Peter-Martin Krarup; Lene Jessen; Mark Berner-Hansen; Lars N Jorgensen; Magnus S Ågren Journal: Gastroenterol Res Pract Date: 2020-10-09 Impact factor: 2.260
Authors: Malene Nerstrøm; Peter-Martin Krarup; Lars Nannestad Jorgensen; Magnus S Ågren Journal: Gastroenterol Res Pract Date: 2017-05-16 Impact factor: 2.260